| Gene symbol | CD33 | Synonyms | CD33rSiglec, SIGLEC-3, SIGLEC3, p67 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.41 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD33 molecule | ||||
| Gene symbol | COLEC10 | Synonyms | 3MC3, CL-10, CL-34, CLL1 | Type of gene | protein-coding |
| Chromosome | 8 | Map location | 8q24.12 | dbXrefs | |
| Description | collectin subfamily member 10 | ||||
| GTO ID | GTC2914 |
| Trial ID | NCT05215015 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | CD33|CLL1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CD33/CLL1 CAR-NK cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Study of Anti-CD33/CLL1 CAR-NK in Acute Myeloid Leukemia |
| Year | 2022 |
| Country | China |
| Company sponsor | Wuxi People's Hospital |
| Cohort 1 | |||||||||||
|
|||||||||||